Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ROIV
ROIV logo

ROIV News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ROIV News

ROIV Options Contract Analysis and Investment Opportunities

5d agoNASDAQ.COM

BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares

Mar 05 2026NASDAQ.COM

BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares

Mar 05 2026Fool

Moderna-Arbutus-Genevant Patent Agreement: Wall Street Views It as Suboptimal, Yet Alleviates Pressure on MRNA Shares

Mar 04 2026stocktwits

Moderna Settles for $950 Million with Arbutus, Eyes Future Growth

Mar 04 2026Benzinga

Moderna Settles for Up to $2.25 Billion with Arbutus and Genevant

Mar 03 2026stocktwits

Moderna Settles for $2.25 Billion with Genevant and Arbutus Over Patent Infringement

Mar 03 2026Globenewswire

Moderna Settles $2.25 Billion Patent Dispute with Genevant and Arbutus

Mar 03 2026Newsfilter

ROIV Events

03/04 16:20
U.S. Service Sector Expansion Boosts Stocks
Stocks ended the day higher after data showed the U.S. service economy expanded at the fastest pace since mid-2022 while a price index hit an almost one-year low, taking attention off geopolitical headlines for a session. The conflict in the Middle East has entered its fifth day and while there have been reports Iran has made indirect contact about potential talks, feeding some risk appetite, uncertainty around the durability of any de-escalation continues to drive positioning and the energy complex continues to influence the broader market's direction. Crude oil prices wavered near $75 per barrel in a volatile session.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Applecontinued a week of new product launches, with the latest being thelaptopGooglesaid it isbrought against the company over its flagship AI product GeminiModernaentered into aworth up to $2.25B with a subsidiary of Roivant Sciencesand Arbutus BiopharmaRoss Storesreported a, raised its quarterly dividend and approved a new two-year $2.55B stock repurchase planFordreportedyear-over-year in February to 149,962 vehicles2. WALL STREET CALLS:BofA reinstated Teslaat Buy as the "Targetat Telsey Advisory and to Market Perform at BernsteinPiper Sandlerat NorthlandLegalZoomat BarclaysFirst Solarat GLJ Research on weak guidance3. AROUND THE WEB:AmazonPublisher Services, which helps websites run ad auctions, is exploring offering technology to help other apps and sites sell ads in AI chatbots, The Information saysOpenAI is developing an alternative to Microsoft'sGitHub, The Information reportsMetais testing a shopping research feature for its AI chatbot that will allow requests for product suggestions, Bloomberg saysThe White House is debating if it will allow Tencentto maintain stakes in popular video game groups, FT reportsDOJ investigating possible price fixing in fertilizer market, Bloomberg reports4. MOVERS:SCHMIDgained afterthe first specialized InfinityLine H+ systemEvolusadvanced afterand providing guidance for FY26Babcock & Wilcoxincreased afterand announcing it has received full notice to proceed on a $2.4B design-build agreement with Base ElectronIndie Semiconductorfell after filing to sell $150M ofGitLabclosed lower afterand authorizing a $400M share repurchase program5. EARNINGS/GUIDANCE:Abercrombie & Fitchreportedand provided guidance for Q1 and FY26Holleyreported, with EPS missing consensusDycomreported Q4 results, withon "strong fourth quarter performance"Bath & Body Worksreported, with EPS and revenue beating consensusBayerreportedand provided guidance for FY26INDEXES:The Dow rose 238.14, or 0.49%, to 48,739.41, the Nasdaq gained 290.79, or 1.29%, to 22,807.48, and the S&P 500 advanced 52.87, or 0.78%, to 6,869.50.
03/04 12:00
Markets Rise Amid Geopolitical Headlines
Markets are higher near noon as geopolitical headlines remain at the center of the tape. The conflict in the Middle East has entered its fifth day and while there have been reports Iran has made indirect contact about potential talks, feeding some risk appetite, uncertainty around the durability of any de-escalation continues to drive positioning. The energy complex continues to influence the broader market's direction as the easing in the recent oil price surge has provided a tailwind, but traders are still cautious amid the ongoing Iran conflict.Global equity markets outside the U.S. are showing stress, with Asian markets taking a particularly severe hit. South Korea's benchmark index experienced one of its largest historical selloffs and other major Asian indices like Japan's Nikkei and Taiwan's TAIEX traded materially lower as well.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Applecontinued a week of, with the latest being the MacBook Neo laptopA subsidiary of Roivant Sciencesand Arbutus Biopharmaentered into a COVID-19with Modernaworth up to $2.25BRoss Storesreported a, raised its quarterly dividend and approved a new two-year $2.55B stock repurchase planCoreWeaveannounced awith Perplexity to support its inference workloadsFordwere down 5.5% year-over-year in February to 149,962 vehicles2. WALL STREET CALLS:BofATeslaat Buy as the "leader" of the next era of mobilityTargetto Outperform at Telsey Advisory and to Market Perform at BernsteinPiper Sandlerto Outperform at NorthlandLegalZoomto Underweight at BarclaysFirst Solarto Hold at GLJ Research on weak guidance3. AROUND THE WEB:AmazonPublisher Services, which helps websites run ad auctions, is exploring offering technology to help other apps and sites sell ads in AI chatbots, The Information saysOpenAI is developing an alternative to Microsoft'sGitHub, The Information reportsMetais testing a shopping research feature for its AI chatbot that will allow requests for product suggestions, Bloomberg saysThe White House is debating if it will allow Tencentto maintain stakes in popular video game groups, FT reportsDraftKing'sstrategy to become a prediction market leader is to copy the formula it used to dominate the online sports betting industry, WSJ reports4. MOVERS:SCHMIDgains in New York afterthe first specialized InfinityLine H+ systemEvolushigher afterand providing guidance for FY26Babcock & Wilcoxincreases afterand announcing it has received full notice to proceed on a $2.4B design-build agreement with Base ElectronIndie Semiconductorfalls after filing to sell $150M ofGitLablower afterand authorizing a $400M share repurchase program5. EARNINGS/GUIDANCEAbercrombie & Fitchand provided guidance for Q1 and FY26Holleywith EPS missing consensusDycom, with CEO Dan Peyovich commenting, "Our strong fourth quarter performance closed a record year for Dycom"Bath & Body Works, with EPS and revenue beating consensusBayerand provided guidance for FY26INDEXES:Near midday, the Dow was up 0.68%, or 329.64, to 48,830.91, the Nasdaq was up 1.46%, or 329.81, to 22,846.51, and the S&P 500 was up 0.87%, or 59.51, to 6,876.14.

ROIV Monitor News

Roivant Sciences benefits from Moderna's patent settlement

Mar 04 2026

Roivant Sciences Stock Soars on Positive Phase 2 Results for Brepocitinib

Feb 09 2026

Roivant Sciences Reports Positive Phase 2 Results for Brepocitinib

Feb 06 2026

Roivant Sciences reaches 5-day high amid market fluctuations

Jan 13 2026

Roivant Sciences Ltd sees stock drop amid market strength

Jan 05 2026

Roivant Sciences Ltd reaches 52-week high amid sector rotation

Dec 16 2025

Roivant Sciences outlines accelerated timelines for key drug developments

Dec 12 2025

Roivant Sciences Ltd reaches a 52-week high amid sector rotation.

Dec 11 2025

ROIV Earnings Analysis

Roivant Sciences Earnings & Drug Discoveries Update- Intellectia AI™
4 months ago
Roivant Sciences Shows Resilience with Strategic Advancements - Intellectia AI™
1 years ago
Roivant Reports Second Quarter Financial Results for 2024
1 years ago

People Also Watch